The activation of α1 AdR may cause CRPS pain and dysautonomia symptoms, while the activation of β2 AdR and M2 anticholinergic receptors (AChRs) may participate in the modulation of pain and inflammation response. Here, ADRB2 is linked to dysautonomia.